We conclude that Rb1 mainly improves the cognitive impairment in the PD animal model, and Rb1-inducing different in vitro and in vivo α-synuclein expression pattern maybe due to the pharmacological metabolism of Rb1. The gene discussed is SNCA; the disease is Cognitive impairment.